Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Apr 17, 2018 · 10-K · 107 days after period end · 0001144204-18-020971
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $32.00K | $71.00K | $863.00K | $872.00K |
| Net Income | -$27.00M | -$30.71M | -$24.08M | -$42.69M |
| EPS Diluted | — | — | -$0.27 | -$0.64 |
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2017 · filed Apr 17, 2018 · 107 d after period end
